Calyx Subsidiary Cannigistics Enters into Memorandum of Understanding for Clinical Trials Software Platform
In: CCNMatthews (Canada), 2015-03-16, S. 3
Zeitungsartikel
Zugriff:
Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) ("Calyx" or "the Company") is pleased to announce that its wholly-owned subsidiary, Cannigistics Agri-Solutions Corp. ("Cannigistics"), has entered into a memorandum of understanding ("MOU") with a third party with respect to the implementation of a clinical trials software platform. The MOU has been signed with a well respected group of Canadian medical specialists that require a secure platform to gather, store, analyze, and report on the results of the trials...
Titel: |
Calyx Subsidiary Cannigistics Enters into Memorandum of Understanding for Clinical Trials Software Platform
|
---|---|
Zeitschrift: | CCNMatthews (Canada), 2015-03-16, S. 3 |
Veröffentlichung: | 2015 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|